(-)-Deprenyl treatment restores serum insulin-like growth factor-I (IGF-I) levels in aged rats to young rat level

Author： De la Cruz C.P.   Revilla E.   Rodrguez-Gomez J.A.   Vizuete M.L.   Cano J.   Machado A.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.327, Iss.2, 1997-05, pp. : 215-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin-like growth factor-I and parathyroid

By Rosen C.J.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1193-1198

Informa Healthcare

Access to resources Recommend Favorite

Mecasermin rinfabate, a once-daily insulin-like growth factor I (IGF-I) replacement therapy, may improve height velocity in children and adolescents

By  

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Induction of choleresis by immunosuppressant FK506 through stimulation of insulin-like growth factor-I production in the liver of rats

By Kawamura I.   Takeshita S.   Fushimi M.   Mabuchi M.   Seki J.   Goto T.  

European Journal of Pharmacology, Vol. 419, Iss. 1, 2001-05 ,pp. : 99-105

Elsevier

Access to resources Recommend Favorite

The insulin-like growth factor-I receptor as a target for cancer therapy

By Baserga Renato  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 753-768

Informa Healthcare

Access to resources Recommend Favorite

Insulin-like growth factor-I receptor – a potential therapeutic target in medulloblastomas

By Reiss Krzysztof  

Expert Opinion on Therapeutic Targets, Vol. 6, Iss. 5, 2002-10 ,pp. : 539-544

Informa Healthcare

Access to resources Recommend Favorite